Glipizide/Metformin Hydrochloride

格列吡嗪/盐酸二甲双胍

Report date: 2022/02/21 15:12:59

Base Information

Drug NameGlipizide/Metformin Hydrochloride
Drug Alias NameGlipizide/metformin HCl格列吡嗪/二甲双胍Glipizide/Metformin格列吡嗪和盐酸二甲双胍glipizide and metformin HCl +[9] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsSulfonylurea receptorProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date2002/10/21
Country/TerritoryUnited StatesMainland China
CombinationsYes Metformin HydrochlorideGlipizide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Miracle Pharmaceutical Co Ltd
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD02
Related LinksKEGG